FDA Inspection 1273734 — Mary Bird Perkins Cancer Center
The FDA completed an inspection of Mary Bird Perkins Cancer Center on Jun 23, 2025 in Hammond, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 23, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hammond, LA (United States)